Remdesivir to be manufactured in Belagavi district

April 30, 2021 07:45 pm | Updated 07:45 pm IST - Belagavi

A Belagavi-based pharmaceutical company has obtained licence to manufacture COVID-19 drug, Remdesivir injection.

Shree Anand Life Sciences, which has plants in Belagavi and Mudhol, will manufacture the injection that is in scarce supply.

Satish Ghargi, who hails from Bagalkot district, has set up Shree Anand Life Sciences pharmaceutical industry in Mudhol and Belagavi. The Belagavi plant is in Honaga Industrial Area.

Minister for Mines and Geology Murugesh Nirani told journalists in Bagalkot on Thursday that the licence would help reduce the scarcity of the drug in the market.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.